Cargando…
Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study
BACKGROUND: Ketamine’s defining side effects are dissociation and increased blood pressure/heart rate. An oral formulation with delayed absorption could minimize these effects. We recently reported safety and tolerability data for an extended release ketamine tablet in healthy volunteers. METHODS: T...
Autores principales: | Glue, Paul, Medlicott, Natalie J., Neehoff, Shona, Surman, Peter, Lam, Fred, Hung, Noelyn, Hung, Cheung-tak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235665/ https://www.ncbi.nlm.nih.gov/pubmed/32523677 http://dx.doi.org/10.1177/2045125320922474 |
Ejemplares similares
-
Ketamine for bipolar depression: an updated systematic review
por: Fancy, Farhan, et al.
Publicado: (2023) -
Psychedelic treatment of functional neurological disorder: a systematic review
por: Butler, Matthew, et al.
Publicado: (2020) -
The therapeutic potential of microdosing psychedelics in depression
por: Kuypers, Kim P.C.
Publicado: (2020) -
Cannabidiol as a potential treatment for psychosis
por: Davies, Cathy, et al.
Publicado: (2019) -
Improvement of functional neurological disorder after
administration of esketamine nasal spray: a case
report
por: Vendrell-Serres, Júlia, et al.
Publicado: (2021)